Ugur Sahin

42PUBLICATIONS
246CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)BiomaterialsMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 04, 2026
Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity.

|Jul 07, 2026
Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8+ T cells.

|Jun 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.

|Mar 28, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Byoung Chul Cho, Rama Balaraman, Hua-Jun Chen

|Feb 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

U Sahin, M Schmidt, E Derhovanessian

|Dec 05, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines.

Wei Chen, Kristin R Tompkins, Ian W Windsor

Pageof 7

Frequent Collaborators

13 joint publications

Alexander Muik

9 joint publications

Kena A Swanson

8 joint publications

Ӧzlem Türeci

8 joint publications

Mathias Vormehr